No profile data available.
Elanco Animal Health Incorporated (ELAN) is a healthcare company in the animal healthcare items industry, based in Indianapolis, United States, with about 9,400 full-time employees.
It reported revenue of $4.72 billion for fiscal year 2025, up 6.2% from fiscal year 2024, and net income of -$232.00 million. In Q2 2026 (the quarter ended June 30, 2026) revenue was $1.37 billion, up 10.2% from a year before. International was its largest region in fiscal year 2025, with 53% of revenue. Its market capitalization was $11.45 billion as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.
Elanco Animal Health reported $4.72 billion in revenue for fiscal year 2025, up 6.2% from $4.44 billion in fiscal year 2024. In Q2 2026 revenue was $1.37 billion.
International: 53% of revenue by region in fiscal year 2025, followed by United States (47%).
$11.45 billion as of October 9, 2026.
Listed companies of a similar size in the same industry (animal healthcare items) include Idexx Laboratories, Inc. (IDXX), Zoetis Inc. (ZTS), Phibro Animal Health Corporation (PAHC), ImmuCell Corporation (ICCC).